REFERENCES
- Jenkins PJ, Sohaib SA, Trainer PJ, Lister TA, Besser GM, Reznek R. Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy. Br J Cancer 1999;80:1815–1819.
- Biswas M, Smith JC, Davies JS. Bilateral adrenal enlargement and non-suppressible hypercortisolism as a presenting feature of gastric cancer. Ann Clin Biochem 2004;41: 494–497.
- Nolten WE, Goldstein D, Lindstrom M, Effects of cytokines in the pituitary–adrenal axis in cancer patients. J Interferon Res 1993;13:349–357.
- Rich T, Innominato PF, Boerner J, Elevated serum cytokines correlated with altered behaviour, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 2005;11:1757–1764.
- Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000;92:994–1000.
- Pacini F, Schlumberger M, Dralle H, European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787–803.
- Schlumberger M, Pacini F. Prognostic factors. In: Thyroid tumors. Paris: Editions Nucleon, 2003:111–125.
- Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
- Schwarz PE, Reimann M, Schutte AE, The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type II diabetes. J Clin Endocrinol Metab 2009;94:920–926.
- Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992;340:1188–1192.
- Trainer PJ, Faria M, Newell-Price J, A comparison of the effect of human and ovine corticotrophin-releasing hormone on the pituitary–adrenal axis. J Clin Endocrinol Metab 1995;80:412–417.
- Spiegel D, Giese-Davis J, Taylor CB, Kraemer H. Stress sensitivity in metastatic breast cancer: analysis of hypothalamic–pituitary–adrenal axis function. Psychoneuroendocrinology 2006;31:1231–1244.
- Jehn CF, Kuehnhardt D, Bartholomae A, Biomarkers of depression in cancer patients. Cancer 2006;107:2723–2729.
- Lundstrom S, Furst CJ. Symptoms in advanced cancer: relationship to endogenous cortisol levels. Palliat Med 2003;17:503–508.
- Rosmond R, Dallman M, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998;83:1853–1859.
- Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000;25:1–35.
- Cutolo M, Foppiani L, Minuto F. Hypothalamic–pituitary–adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia pheumatica. J Endocrinol Invest 2002;25(10 Suppl.):19–23.
- Orth DN. Corticotropin-releasing hormone in humans. Endocr Rev 1992; 13:164–191.
- Walker M, Berrish TS, James AR, Alberti KGMM. Effect of hyperinsulinaemia on the function of the pituitary–adrenal axis in healthy men. Clin Endocrinol 1994;40: 493–498.
- Chrisoulidou A, Pazaitou-Panayiotou K, Kaprara A, Effects of thyroxine withdrawal in biochemical parameters and cardiac function and structure in patients with differentiated thyroid cancer. Minerva Endocrinol 2006;31:173–178.
- Lizcano F, Salvador J. Effects of different treatments for hyperthyroidism on the hypothalamic–pituitary–adrenal axis. Clin Exp Pharmacol Physiol 2008;35:1085–1090.
- Tsatsoulis A, Johnson EO, Kalogera CH, Seferiadis K, Tsolas O. The effect of thyrotoxicosis on adrenocortical reserve. Eur J Endocrinol 2000;142:231–235.
- Weber-Hamann B, Hentschel F, Kniest A, Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom Med 2002;64:274–277.
- Nuver J, Smit AJ, Wolffenbuttel BHR, The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 2005;23:3718–3725.